In
the sensitive tumor models, the ability of anti — cytotoxic T lymphocyte — associated protein 4 or anti — programmed cell death 1 therapy to increase vessel perfusion strongly correlated with its antitumor efficacy.
Not exact matches
«We hope that our mouse
model, which allows us to combine drug testing and genetic analysis, will provide a deeper understanding of why
tumors are
sensitive or resistant to drugs,» states Ian Frew.
Here, we show that ICB increased
tumor vessel perfusion in treatment -
sensitive EO771 and MMTV - PyVT breast
tumor as well as CT26 and MCA38 colon
tumor models, but not in treatment - resistant MCaP0008 and 4T1 breast
tumor models.
Injecting breast cancer with oxygen - filled microbubbles makes
tumors three - times more
sensitive to radiation therapy and improves survival in animal
models of the disease.